ALTIMMUNE, INC.

MD

Clinical stage biopharmaceutical company

Active 2020–2022. The register lists this client once for every firm that files on its behalf; all 3 of its records are shown together here.

Filings
17
Filed By
3
Reported In-House
—
Reported By Firms
$565,000

Filings

YearFirmPeriodAmountDoc
2022 BGR GOVERNMENT AFFAIRS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Termination (No Activity)
—
2021 BGR GOVERNMENT AFFAIRS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report (No Activity)
—
2021 BGR GOVERNMENT AFFAIRS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report (No Activity)
—
2021 BGR GOVERNMENT AFFAIRS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$80,000
2021 VAN SCOYOC ASSOCIATES 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Termination
$50,000
2021 BGR GOVERNMENT AFFAIRS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$80,000
2021 VAN SCOYOC ASSOCIATES 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$40,000
2020 BGR GOVERNMENT AFFAIRS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$90,000
2020 VAN SCOYOC ASSOCIATES 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$50,000
2020 BGR GOVERNMENT AFFAIRS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$80,000
Page 1 of 2  ·  17 filings Next
Filed By
FirmFilingsAmount
BGR GOVERNMENT AFFAIRS 8 $330,000
VAN SCOYOC ASSOCIATES 6 $200,000
BRADLEY ARANT BOULT CUMMINGS LLP 3 $35,000
Issue Areas